BR9915900A - Compound, pharmaceutical composition, and process for treating or inhibiting disorders associated with smooth muscle contraction. - Google Patents

Compound, pharmaceutical composition, and process for treating or inhibiting disorders associated with smooth muscle contraction.

Info

Publication number
BR9915900A
BR9915900A BR9915900-7A BR9915900A BR9915900A BR 9915900 A BR9915900 A BR 9915900A BR 9915900 A BR9915900 A BR 9915900A BR 9915900 A BR9915900 A BR 9915900A
Authority
BR
Brazil
Prior art keywords
compound
pharmaceutical composition
smooth muscle
disorders associated
muscle contraction
Prior art date
Application number
BR9915900-7A
Other languages
Portuguese (pt)
Inventor
Schuyler A Antane
John A Butera
Joseph R Lennox
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of BR9915900A publication Critical patent/BR9915900A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered

Abstract

"COMPOSTO, COMPOSIçãO FARMACêUTICA, E, PROCESSO PARA TRATAR OU INIBIR DISTúRBIOS ASSOCIADOS COM CONTRAçãO DA MUSCULATURA LISA" Compostos de Fórmulas (I) e (II): onde R~ 1~, R~ 2~, R~ 3~, X, Y e Z são como definidos na especificação compostos estes úteis no tratamento de distúrbios associados com contração de musculatura lisa via modulação por canal de potássio."COMPOUND, PHARMACEUTICAL COMPOSITION, AND, PROCESS TO TREAT OR INHIBIT DISTURBANCES ASSOCIATED WITH SMOOTH MUSCULATURE CONTRACTION" Compounds of Formulas (I) and (II): where R ~ 1 ~, R ~ 2 ~, R ~ 3 ~, X, Y and Z are as defined in the specification compounds which are useful in the treatment of disorders associated with smooth muscle contraction via potassium channel modulation.

BR9915900-7A 1998-12-04 1999-12-03 Compound, pharmaceutical composition, and process for treating or inhibiting disorders associated with smooth muscle contraction. BR9915900A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20577098A 1998-12-04 1998-12-04
PCT/US1999/028619 WO2000034285A2 (en) 1998-12-04 1999-12-03 Substituted benzofuranoindoles and indenoindoles as novel potassium channel openers

Publications (1)

Publication Number Publication Date
BR9915900A true BR9915900A (en) 2001-08-21

Family

ID=22763580

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9915900-7A BR9915900A (en) 1998-12-04 1999-12-03 Compound, pharmaceutical composition, and process for treating or inhibiting disorders associated with smooth muscle contraction.

Country Status (7)

Country Link
EP (1) EP1135393A2 (en)
JP (1) JP2002531569A (en)
CN (1) CN1333774A (en)
AU (1) AU2163600A (en)
BR (1) BR9915900A (en)
CA (1) CA2350590A1 (en)
WO (1) WO2000034285A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101072780B (en) * 2004-09-20 2010-06-23 詹森药业有限公司 Novel tetracyclic derivative containing heteroatoms useful as sex steroid hormone receptor modulators
KR100659498B1 (en) * 2005-03-10 2006-12-20 애니젠 주식회사 Potassium channel opener having benzofuroindole skeleton
AU2006267077A1 (en) 2005-07-14 2007-01-18 Irm Llc Heterotetracyclic compounds as TPO mimetics
JP6091445B2 (en) * 2013-02-07 2017-03-08 富士フイルム株式会社 Organic thin film transistor, organic semiconductor thin film and organic semiconductor material
PL3292116T3 (en) 2015-02-02 2022-02-21 Valo Health, Inc. 3-aryl-4-amido-bicyclic [4,5,0]hydroxamic acids as hdac inhibitors
TW201636329A (en) 2015-02-02 2016-10-16 佛瑪治療公司 Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors
WO2017218950A1 (en) 2016-06-17 2017-12-21 Forma Therapeutics, Inc. 2-spiro-5- and 6-hydroxamic acid indanes as hdac inhibitors
CN106632360A (en) * 2016-09-27 2017-05-10 上海道亦化工科技有限公司 Compound based on benzofuroindole and organic electroluminescent device thereof
CN109942545A (en) * 2019-04-15 2019-06-28 中国药科大学 Competitive sour retarding agent of potassium ion containing indole structure and preparation method thereof and purposes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8902273D0 (en) * 1989-06-22 1989-06-22 Univ Cincinnati INDENOINDOLE COMPOUNDS I
SE8902274D0 (en) * 1989-06-22 1989-06-22 Univ Cincinnati INDENOIDOLE COMPOUNDS II
MC2251A1 (en) * 1990-03-20 1993-03-25 Wellcome Found BIOCIDAL HETEROCYCLIC COMPOUNDS, THEIR SYNTHESIS AND THEIR INTERIORS, COMPOSITIONS CONTAINING THEM AND THEIR USE IN MEDICINE

Also Published As

Publication number Publication date
AU2163600A (en) 2000-06-26
WO2000034285A2 (en) 2000-06-15
CN1333774A (en) 2002-01-30
WO2000034285A3 (en) 2000-11-16
CA2350590A1 (en) 2000-06-15
JP2002531569A (en) 2002-09-24
EP1135393A2 (en) 2001-09-26

Similar Documents

Publication Publication Date Title
BR0209129A (en) Compounds, pharmaceutical compositions, methods for treating pain, methods for modulating a pharmacological response and uses of compounds.
DE69527987D1 (en) FORMULATIONS AND METHOD FOR REDUCING SKIN IRRITATION
BR9713465A (en) Cytically substituted amine metallotprotease inhibitors
BR9709959A (en) Tricyclic derivatives of substituted phenylamino for the treatment of hyperproliferative diseases
DE69909818D1 (en) PYRAZOLOPYIMIDINONE DERIVATIVES FOR TREATING IMPOTENCE
BR0114321A (en) Compound, pharmaceutical composition, use of a compound, method of treating or prophylaxis of inflammatory diseases, and process for preparing a compound
BR0111898A (en) Methods of treating cell proliferation disorders, and a disorder associated with ksp kinesin activity, ksp kinesin inhibition method, compound, screening method for kps kinesin modulators, and method of screening compounds that bind to kinesin ksp
BR9811685A (en) Pyridine derivatives
BR0107241A (en) Compounds, process of preparation of compounds, use of compounds, fungicidal compositions, process of preventive or curative control of plant pathogenic fungi of the cultures and method of preventive or curative treatment of construction wood
BR0114576A (en) Compound, pharmaceutical composition, use of a compound, method of treating a disease state and process for preparing a compound
BR0012934A (en) Processes for reducing pain and anxiety
CY1111912T1 (en) METHOD OF RESTRICTING OSTEOKLASTS ACTIVITY
BR9610838A (en) Process for treating an individual having a pathological condition involving neovascularization.
BR9911240A (en) Composition to inhibit the growth of microorganisms, and, process to control the growth of microorganisms in industrial process water
PT1117672E (en) Antisense modulation of survivin expression
ES2191066T3 (en) ENANTIOSELECTIVA PREPARATION OF PHARMACEUTICALLY ACTIVE SULFOXIDES BY BIOOXIDATION.
ATE238792T1 (en) USE OF MACROLIDS TO TREAT GLAUCOMA
BR9915900A (en) Compound, pharmaceutical composition, and process for treating or inhibiting disorders associated with smooth muscle contraction.
ATE352639T1 (en) ANTISENSE MODULATION OF EXPRESSION OF INTEGRIN ALPHA 4
BR0209128A (en) Compounds, pharmaceutical compositions, methods for treating pain, methods for modulating a pharmacological response and uses of compounds
BR9916680A (en) Derivatives of 3,3-biarylpiperidine and 2,2-biarylmorpholine
WO2004016754A3 (en) ANTISENSE MODULATION OF Nav1.3 EXPRESSION
ATE321045T1 (en) METHODS AND COMPOSITIONS FOR TREATING PAIN
TR199900153T2 (en) Substituted bisindolylmaleimides to prevent cell proliferation.
BR9813634A (en) "potassium channel openers"

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired